計算生物学市場：サービス、用途、最終用途別-2024-2030年の世界予測

計算生物学市場規模は、2023年に62億5,000万米ドルと推計され、2024年には74億2,000万米ドルに達し、CAGR 18.91％で2030年には210億1,000万米ドルに達すると予測されています。

計算生物学は、コンピュータサイエンス、応用数学、統計学、バイオインフォマティクスの技術を応用して生物学の複雑な問題を解決し、生物学的データを理解し、生物システムをモデル化する学際的な領域です。生物学、行動学、社会システムの研究に、理論的手法やデータ解析、計算シミュレーション技術、数理モデリングの開発と応用を包含します。この技術の主な目的は、生物学的システムの原理とダイナミクスに関する洞察を得ること、およびその行動と相互作用を予測することです。計算生物学はバイオインフォマティクスの分野と密接に関連していますが、理論的アプローチと計算モデルの開発に重点を置く傾向があります。計算生物学市場は、創薬や個別化医療のニーズの高まり、バイオインフォマティクス分野の進歩、複雑な生物学的データ量の増加によって牽引されています。ゲノミクスとプロテオミクスの研究開発に対する政府や民間の資金援助も市場拡大を支えています。成長の見込みはあるもの、専門的な計算インフラストラクチャの必要性、計算ツールに関連する高コスト、生物学的データを分析する熟練した専門家の不足が、計算生物学の対象範囲の妨げとなっています。さらに、データのセキュリティやプライバシーに関する懸念、ヘルスケア関連データの規制遵守の複雑さが、市場普及のハードルとなっています。しかし、人工知能と機械学習アルゴリズムの統合は、予測モデリングとデータ分析能力を強化することで、市場成長の有利な機会をさらにもたらしています。さらに、バイオマーカー探索と精密医療におけるその役割への注目の高まりは、市場拡大の新たな機会を開く。

サービス機密データや独自の調査を扱う計算生物学内製化のメリット

計算生物学のダイナミックな分野では、契約ベースのサービスが、フルタイム雇用のオーバーヘッドなしに専門的な知識を求める組織にとって、柔軟なソリューションとして際立っています。外部プロバイダーや個々のコンサルタントが提供するこれらのサービスは、特定のプロジェクト需要やスケジュールに合わせて調整されるため、高度な分析スキルや最先端のアルゴリズム開発、カスタムバイオインフォマティクスソフトウェアソリューションを一時的またはプロジェクト単位で必要とする企業にとって、貴重なリソースとなります。対照的に、インハウスの計算生物学サービスは、組織の恒久的な運営体制に統合されています。このアプローチにより、計算生物学の専門知識への一貫した長期的な投資が可能となり、企業の特定の研究分野や方法論への深い理解が育まれます。インハウスチームは、組織のデータ、目的、プロセスに精通しているため、アウトプットをビジネスの戦略的目標と密接に連携させることができます。長期的に変化する企業のニーズに適応できる、安定的かつ継続的に進化するリソースを提供します。

アプリケーション医薬品開発パイプラインを合理化するための計算生物学の重要な応用例

細胞生物学シミュレーションでは、計算モデルを使用して生物学的細胞の挙動や相互作用をシミュレートします。これらのシミュレーションは、細胞機能、生物学的挙動、および様々な刺激に対する応答の理解と予測に役立ち、基礎研究と応用生物医学アプリケーションの両方に不可欠です。この技術は、複雑な生化学的経路の調査や、in vitroやin vivoで行うにはコストがかかったり技術的に困難であったりするin silico実験に特に適しています。臨床試験とは、新薬、医療機器、治療プロトコルの有効性をヒトを対象として判定するために行われる実験的調査です。計算生物学は臨床試験のデザインと解析において極めて重要な役割を果たし、試験デザイン、患者層別化、データ解析の効率を向上させます。創薬と疾患モデリングは計算生物学の重要なアプリケーションであり、化合物のコンピュータ支援設計（CAD）と疾患経路のモデリングは、新しい治療薬の発見を加速します。これらの手法は、それぞれ広大な化学空間の探索と複雑な疾患のモデリングを可能にし、新薬の潜在的な標的や分子を特定します。人体シミュレーションソフトウェアは、人体の解剖学的および生理学的側面をモデル化するために設計された、広範な計算ツール群を包含しています。これらのシミュレーションは、医療機器の設計、手術計画、教育目的など、さまざまな用途に使用されています。前臨床医薬品開発は、医薬品開発プロセスにおいて臨床試験に先行する研究段階です。候補薬の薬物動態、薬力学、毒性を予測するために、インシリコモデルやシミュレーションツールを使用します。

最終用途応用研究の課題に取り組む営利企業における計算生物学の採用拡大

学術分野では、計算生物学ツールは主に研究や教育目的で使用されています。最先端技術へのアクセシビリティ、学生や研究者の使いやすさ、費用対効果が重視されます。学術機関では、進化生物学からシステム生物学に至る多様な研究のために、広範なデータベースと計算能力を必要とすることがよくあります。製薬会社やバイオテクノロジー企業などの営利団体は、創薬や薬剤開発、個別化医療、アグリゲノミクスへの計算生物学の応用を優先しています。これらの分野では、データのセキュリティと知的財産の保護に重点を置いた、堅牢で拡張性の高いソリューションが求められています。

地域別インサイト

南北アメリカ、特に北米の計算生物学市場は力強い成長を示しています。定評ある製薬会社の存在、洗練されたヘルスケアインフラ、厳格な研究開発活動が、この地域の市場拡大を後押ししています。ゲノミクスとプロテオミクスへの大規模投資が、計算生物学ソリューションの需要をさらに促進しています。米国は、政府の支援政策、産学連携の充実、この分野に熟練した専門家を供給するバイオインフォマティクス関連講座の増加などに支えられ、依然として最前線にあります。EMEA（欧州・中東・アフリカ）地域は、特に欧州における民間および公的機関による資金提供の増加により、計算生物学市場が大幅に急増しています。医薬品開発のための効率的な規制の枠組みや卓越した科学研究の伝統が、この地域の市場躍進を後押ししています。ドイツ、英国、フランスはバイオテクノロジーと計算科学に力を入れており、主要な貢献国です。中東は、主にバイオテクノロジー分野への政府の戦略的投資によって着実に追い上げており、アフリカは発展の初期段階にあります。アジア太平洋は計算生物学市場のダイナミックな成長ハブとして台頭しつつあります。急速な経済発展、ヘルスケア支出の増加、急成長するバイオテクノロジー産業が市場情勢を特徴づけています。同地域の国々は、政府の支援、ライフサイエンス分野の教育・研究への注力、個別化医療への関心の高まりにより、市場プレーヤーに有利な機会を提供しています。国境を越えた協力関係や海外からの投資の流入がこの市場をさらに特徴づけており、APACは競争力があり将来性の高い地域と位置づけられています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは計算生物学市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、計算生物学市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.計算生物学市場の市場規模および予測は？

2.計算生物学市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.計算生物学市場の技術動向と規制枠組みは？

4.計算生物学市場における主要ベンダーの市場シェアは？

5.計算生物学市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 個別化医療のニーズの高まり
    • バイオインフォマティクス調査の発展と臨床研究の増加
    • 腫瘍治療における計算生物学の採用
  • 抑制要因
    • 計算ツールを操作する熟練した専門家の不足
  • 機会
    • 細胞モデリングにおけるバイオインフォマティクスとマルチスケール生物学的モデリングの利用の加速
    • バイオインフォマティクスへの資金提供の増加と計算生物学分野の進歩
  • 課題
    • 相互運用性とマルチプラットフォーム機能の不足、明確に定義された標準の欠如
• 市場セグメンテーション分析
  • サービス：機密データや独自の調査を扱う社内計算生物学機能の利点
  • アプリケーション：医薬品開発パイプラインを合理化するための計算生物学の重要なアプリケーション
  • 最終用途：応用調査の課題に取り組む商業組織における計算生物学の採用の増加
• 市場動向分析
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析
• 顧客のカスタマイズ

第6章 計算生物学市場：サービス別

• 契約
• 社内

第7章 計算生物学市場：用途別

• 細胞生物学的シミュレーション
• 臨床試験
• 創薬と疾患モデリング
• 人体シミュレーションソフトウェア
• 前臨床医薬品開発

第8章 計算生物学市場：最終用途別

• 学術
• 商業用

第9章 南北アメリカの計算生物学市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の計算生物学市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの計算生物学市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • バイオインフォマティクス、計算生物学、健康データサイエンスの分野でキャリアを築くカナダの若手研究者向けの新たな資金が利用可能
  • Pluto、Silverton Partners主導による370万米ドルのシードラウンドを発表
  • アクセンチュア、AIを活用した創薬と個別化医療の開発を加速するため、オーシャンゲノミクスに投資

第13章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. COMPUTATIONAL BIOLOGY MARKET RESEARCH PROCESS
• FIGURE 2. COMPUTATIONAL BIOLOGY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. COMPUTATIONAL BIOLOGY MARKET DYNAMICS
• FIGURE 7. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. COMPUTATIONAL BIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. COMPUTATIONAL BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. COMPUTATIONAL BIOLOGY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY IN-HOUSE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CELLULAR BIOLOGICAL SIMULATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CELLULAR BIOLOGICAL SIMULATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & DISEASE MODELLING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & DISEASE MODELLING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY HUMAN BODY SIMULATION SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY HUMAN BODY SIMULATION SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRECLINICAL DRUG DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRECLINICAL DRUG DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY COMMERCIAL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 32. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 33. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 34. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 35. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 36. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 37. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 38. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 39. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 40. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 41. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 42. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 43. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 44. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 45. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 46. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 47. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 48. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 49. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 50. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 51. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 52. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 53. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 54. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 55. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 56. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 57. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 58. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 59. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 60. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 61. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 62. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 63. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 64. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 65. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 66. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 67. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 68. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 69. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 70. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 72. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 74. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 76. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 78. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 79. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 80. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 81. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 82. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 83. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 84. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 85. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 86. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 87. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 88. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 89. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 90. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 91. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 92. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 93. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 94. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 95. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 96. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 97. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 98. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 99. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 100. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 101. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 102. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 103. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 104. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 105. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 106. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 107. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 108. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 109. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 110. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 111. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 112. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 113. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 114. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 115. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 116. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 117. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 118. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 119. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 120. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 121. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 122. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 123. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 124. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 125. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 126. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 128. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 130. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 132. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 133. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 134. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 135. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 136. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 137. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 138. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 139. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 140. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 141. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 142. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 143. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 144. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 145. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 146. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 147. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 148. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 149. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 150. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 159. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 160. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 161. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 162. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 163. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 164. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 165. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 166. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 167. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 168. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 169. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 170. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 171. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 172. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 173. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 174. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 175. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 176. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 177. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 178. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 179. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 180. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 181. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 182. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 183. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 184. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 185. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 186. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 187. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 188. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 189. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 190. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 191. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 192. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 193. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 194. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 195. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 196. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 197. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 198. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 199. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 200. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 201. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 202. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 203. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 204. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 205. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 206. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 207. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 208. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 209. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 210. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 211. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 212. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 213. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 214. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 215. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 216. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 217. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 218. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 219. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 220. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 221. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 222. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 223. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 224. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 225. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 226. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 227. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 228. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 229. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 230. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 231. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 232. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 233. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 234. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 235. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 236. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 238. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 240. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 242. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 244. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 246. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 248. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 249. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 250. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 251. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 252. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 253. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 254. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 255. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 256. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 257. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 258. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 259. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 260. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 261. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 262. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 263. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 264. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 265. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 266. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 267. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 268. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 269. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 270. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 271. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 272. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 278. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 280. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 282. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 284. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 285. COMPUTATIONAL BIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 286. COMPUTATIONAL BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

[193 Pages Report] The Computational Biology Market size was estimated at USD 6.25 billion in 2023 and expected to reach USD 7.42 billion in 2024, at a CAGR 18.91% to reach USD 21.01 billion by 2030.

Computational biology is an interdisciplinary domain that applies techniques from computer science, applied mathematics, statistics, and bioinformatics to solve complex problems in biology, understand biological data, and model biological systems. It encompasses the development and application of theoretical methods and data-analytical, computational simulation techniques, and mathematical modeling to the study of biological, behavioral, and social systems. The primary aim of this technology is to generate insights into the principles and dynamics of biological systems, as well as to predict their behaviors and interactions. Computational biology is closely related to the field of bioinformatics but tends to focus more on the development of theoretical approaches and computational models. The computational biology market is driven by the increasing need for drug discovery and personalized medicine, advancements in the field of bioinformatics, and the rise in the volume of complex biological data. Government and private funding for research and development in genomics and proteomics also support the market expansion. Despite growth prospects, the need for specialized computational infrastructure, high costs associated with computational tools, and a shortage of skilled professionals to analyze biological data hinder the scope of computational biology. Moreover, concerns regarding data security and privacy and the complexity of regulatory compliances for healthcare-related data create hurdles in market proliferation. However, an integration of artificial intelligence and machine learning algorithms is further presenting lucrative opportunities for market growth by enhancing predictive modeling and data analysis capabilities. Moreover, the rising focus on biomarker discovery and its role in precision medicine opens up new opportunities for the market's expansion.

Services: Benefits of in-house computational biology capabilities to handle sensitive data or proprietary research

In the dynamic field of computational biology, contract based services stand out as a flexible solution for organizations seeking specialized expertise without the overhead of full-time employment. These services, offered by external providers or individual consultants, are tailored to meet the specific project demands and timelines, making them an invaluable resource for companies that require advanced analytical skills, state-of-the-art algorithm development, or custom bioinformatics software solutions on a temporary or per-project basis. In contrast, in-house computational biology services are integrated within an organization's permanent operational structure. This approach allows for a consistent and long-term investment in computational biology expertise, fostering a deep understanding of the company's specific research areas and methodologies. In-house teams are intimately familiar with the data, objectives, and processes of their organization, enabling them to align their output closely with the strategic goals of the business. They provide a stable and continually evolving resource capable of adapting to the company's changing needs over time.

Application: Significant applications of computational biology to streamline the drug development pipeline

Cellular biological simulation involves the use of computational models to simulate the behaviors and interactions of biological cells. These simulations help to understand and predict cellular functions, biological behaviors, and responses to various stimuli, which is critical for both basic research and applied biomedical applications. The technology is especially relevant for investigating complex biochemical pathways and in silico experimentation, which can be cost-prohibitive or technically challenging to perform in vitro or in vivo. Clinical trials are experimental research studies conducted to determine the efficacy of new drugs, medical devices, or treatment protocols on human subjects. Computational biology plays a pivotal role in the design and analysis of clinical trials, improving the efficiency of trial designs, patient stratification, and data analysis. Drug discovery & disease modeling are crucial applications of computational biology where computer-aided design (CAD) for drug compounds and modeling of disease pathways accelerate the discovery of new therapeutics. These methods enable the exploration of vast chemical spaces and the modeling of complex diseases, respectively, to identify potential targets and molecules for new drugs. Human body simulation software encompasses a broad set of computational tools designed to model anatomical and physiological aspects of the human body. These simulations are employed for a variety of applications, including medical device design, surgical planning, and educational purposes. Preclinical drug development is the phase of research that precedes clinical trials in the drug development process. It involves the use of in silico models and simulation tools to predict the pharmacokinetics, pharmacodynamics, and toxicity of candidate drugs.

End-Use: Growing adoption of computational biology in commercial entities to tackle applied research challenges

In academic settings, computational biology tools are primarily used for research and educational purposes. The emphasis is on accessibility to cutting-edge technology, ease of use for students and researchers, and cost-effectiveness. Academic institutions often require extensive databases and computational power for diverse research ranging from evolutionary biology to systems biology. Commercial entities, including pharmaceutical and biotech companies, prioritize the application of computational biology for drug discovery and development, personalized medicine, and agrigenomics. These sectors seek robust, scalable solutions with a strong emphasis on data security and intellectual property protection.

Regional Insights

The computational biology market in the Americas, particularly in North America, is exhibiting robust growth. The presence of established pharmaceutical companies, sophisticated healthcare infrastructure, and rigorous research and development activities are propelling the region's market expansion. Large-scale investments in genomics and proteomics are further spurring demand for computational biology solutions. The United States remains at the forefront, backed by supportive government policies, substantial academic-industry collaborations, and an increase in bioinformatics-related courses that supply skilled professionals to the field. The EMEA region has been experiencing a significant surge in the computational biology market owing to increased funding by private and public entities, particularly in Europe. Efficient regulatory frameworks for drug development and a tradition of excellence in scientific research are driving the market's progress in this region. Germany, the UK, and France are major contributors with their strong focus on biotechnology and computational sciences. The Middle East is steadily catching up, largely due to strategic government investments in the biotech sector, while Africa is in the early stages of development. Asia-Pacific is emerging as a dynamic growth hub for the computational biology market. Rapid economic development, increasing healthcare expenditure, and a burgeoning biotechnology industry characterize the market landscape. Countries in the region are providing lucrative opportunities for market players owing to governmental backing, a focus on education and research in the life sciences, and a rising emphasis on personalized medicine. Cross-border collaborations and the inflow of foreign investments are further defining this market, positioning APAC as a competitive and high-potential region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Computational Biology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Computational Biology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Computational Biology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., BGI Group, Biomax Informatics AG, Chemical Computing Group Inc., Compugen Ltd., Dassault Systemes SE, DNAnexus, Inc., DNASTAR, Inc., Eurofins Scientific SE, Genedata AG, Illumina, Inc., Insilico Medicine, Instem Group, Nimbus Discovery Llc, Ocean Genomics, PerkinElmer, Inc., Pluto Bioinformatics, ProFound Therapeutics, QIAGEN N.V., Rosa & Co. Llc, Schrodinger, Inc., Simulation Plus Inc., SOPHiA GENETICS, Thermo Fisher Scientific Inc., Waters Corporation, and WuXi NextCODE.

Market Segmentation & Coverage

This research report categorizes the Computational Biology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Services
  • Contract
  • In-house

• Application
  • Cellular Biological Simulation
  • Clinical Trials
  • Drug Discovery & Disease Modelling
  • Human Body Simulation Software
  • Preclinical Drug Development

• End-Use
  • Academics
  • Commercial

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Computational Biology Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Computational Biology Market?

3. What are the technology trends and regulatory frameworks in the Computational Biology Market?

4. What is the market share of the leading vendors in the Computational Biology Market?

5. Which modes and strategic moves are suitable for entering the Computational Biology Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising Need for Personalized Medicine
    • 5.1.1.2. Growing Bioinformatics Research and Increasing Number of Clinical Studies
    • 5.1.1.3. Adoption of Computational Biology in Oncology Therapeutics
  • 5.1.2. Restraints
    • 5.1.2.1. Dearth of Skilled Professionals to Operate Computational Tools
  • 5.1.3. Opportunities
    • 5.1.3.1. Accelerating Use of Bioinformatics and Multiscale Biological Modeling in Cell Modeling
    • 5.1.3.2. Increased Funding in Bioinformatics Coupled with Advancements in the Field of Computational Biology
  • 5.1.4. Challenges
    • 5.1.4.1. Insufficiency of Interoperability and Multiplatform Capabilities and Lack of Well-Defined Standards
• 5.2. Market Segmentation Analysis
  • 5.2.1. Services: Benefits of in-house computational biology capabilities to handle sensitive data or proprietary research
  • 5.2.2. Application: Significant applications of computational biology to streamline the drug development pipeline
  • 5.2.3. End-Use: Growing adoption of computational biology in commercial entities to tackle applied research challenges
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework Analysis
• 5.9. Client Customization

6. Computational Biology Market, by Services

• 6.1. Introduction
• 6.2. Contract
• 6.3. In-house

7. Computational Biology Market, by Application

• 7.1. Introduction
• 7.2. Cellular Biological Simulation
• 7.3. Clinical Trials
• 7.4. Drug Discovery & Disease Modelling
• 7.5. Human Body Simulation Software
• 7.6. Preclinical Drug Development

8. Computational Biology Market, by End-Use

• 8.1. Introduction
• 8.2. Academics
• 8.3. Commercial

9. Americas Computational Biology Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Computational Biology Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Computational Biology Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. New Funds Available for Early Career Canadian Researchers Building Careers in Bioinformatics, Computational Biology, or Health Data Sciences
  • 12.3.2. Pluto Announces USD 3.7M Seed Round, Led by Silverton Partners
  • 12.3.3. Accenture Invests in Ocean Genomics to Accelerate AI-driven Drug Discovery and the Development of Personalized Medicines

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio